Refractive cash-pay economics

Refractive surgery is the cleanest cash-pay surgical model. Here’s the operating economics.

It’s a simple, powerful premise: a patient pays you directly, in cash, for a high-value procedure. No prior authorizations, no downcoding, no waiting 90 days for a payer to remit 70% of the contracted rate. This direct-to-consumer model is the envy of other specialties, but the procedural revenue is only the first layer. The real, multi-generational wealth from a successful refractive practice comes from the corporate and tax architecture you build around that cash flow. Most of us learn this the hard way—by leaving hundreds of thousands of dollars on the table for years before getting the right advice.

This isn’t about finding a better mutual fund. It’s about structuring your entities—your practice, your surgery center, your real estate—to legally and ethically minimize your tax burden, allowing you to reinvest more capital into growing your enterprise and your net worth. We’ll walk through the core strategies that separate a high-income surgeon from a truly wealthy one. For a broader look at the clinical and operational side, you can explore the full ophthalmology hub for more resources.

The ASC Ownership Play: K-1s and Active Participation

For many ophthalmologists, the first major wealth-building step beyond their practice is buying into an Ambulatory Surgery Center (ASC). This isn’t just an investment; it’s a fundamental shift in your financial DNA. You move from being solely a W-2 employee or S-Corp owner of your practice to a partner in a separate entity, and that means you start getting a Schedule K-1.

Here’s how it works. The ASC, typically structured as a partnership or LLC taxed as a partnership, generates its own profit and loss. As a partner, you receive a K-1 that reports your pro-rata share of that income, gain, loss, and deductions. This income isn’t salary; it flows through to your personal tax return and you pay tax on it, whether or not the cash was actually distributed to you. This is a critical concept many physicians miss early on: you can owe tax on “phantom income” that the ASC retains for operational purposes.

The key tax planning lever is your level of participation. The IRS has strict rules under §469 that define “active” versus “passive” participation. Why does this matter? If your ASC generates a loss in a given year (common in the early years or after a major equipment purchase), you can only deduct that loss against other passive income unless you qualify as an active participant. To be considered active, you generally need to meet one of several “material participation” tests, the most common of which for physicians is spending more than 500 hours per year in the activity.

A common trap is assuming that because you operate at the ASC, you are automatically an active participant. This isn’t always true from a tax perspective, especially if your role is limited to clinical duties. Your ability to make management decisions, your hours spent on administrative tasks for the ASC, and your overall involvement determine your status. Getting this wrong means a valuable tax deduction for losses could be suspended until you have passive income to offset it or you sell your stake. When you’re evaluating a potential buy-in or planning a new build-out, modeling the financial pro formas is essential. An ASC/OBL feasibility advisory engagement can help map out the capital requirements, revenue projections, and tax implications before you commit.

Your Practice’s Landlord: Building Wealth with a Real Estate LLC

One of the most powerful and time-tested strategies for surgical specialists is to own the real estate where you practice. The structure is straightforward: you and your partners form a separate LLC to buy or develop the medical office building. This real estate LLC then leases the property back to your medical practice at a fair market rate.

This creates two distinct economic engines.

1. The Medical Practice: Your practice pays rent to the real estate LLC. This rent is a fully deductible business expense, reducing the practice’s taxable income.
2. The Real Estate LLC: The LLC receives rental income. After paying its own expenses (mortgage, insurance, taxes), the remaining profit is distributed to you and the other owners.

The real magic happens on the tax side. Commercial real estate allows for massive depreciation deductions. Better yet, you can commission a cost segregation study. Instead of depreciating the entire building over 39 years, a cost segregation study identifies components that can be depreciated much faster—over 5, 7, or 15 years. This includes things like carpeting, specialty electrical wiring, cabinetry, and landscaping. This front-loads your depreciation deductions, creating large “paper losses” in the early years of ownership, which can offset your rental income and even become a net loss.

Here’s the advanced maneuver: If your spouse can qualify for Real Estate Professional Status (REPS), those paper losses from the real estate LLC are no longer automatically considered “passive.” They can potentially be used to offset your high W-2 or K-1 income from your surgical practice. To qualify for REPS, a person must:

• Spend more than 750 hours during the tax year in real property trades or businesses.
• Spend more than 50% of their total working time on these real estate activities.

The planning trap here is documentation. The IRS heavily scrutinizes REPS claims. Your spouse must maintain a contemporaneous log of their time. A simple spreadsheet tracking dates, hours, and specific activities is usually sufficient, but you can’t reconstruct it years later during an audit. This strategy alone can save high-earning surgeons tens or even hundreds of thousands of dollars in taxes annually.

The Ultimate Pre-Tax Shelter: Stacking a Cash Balance Plan

Most physicians are familiar with a 401(k) or profit-sharing plan. These are great, but for a high-earning refractive surgeon in their 40s or 50s, they are often insufficient. Once you’re consistently maxing out your 401(k) contributions (around $76,500 in 2026 for an employee/employer combo with catch-up), the next and most powerful tool is a cash balance plan.

A cash balance plan is a type of IRS-qualified defined-benefit pension plan. Unlike a 401(k) (a defined-contribution plan where the outcome depends on market performance), a defined-benefit plan promises a specific payout at retirement. To fund that future promise, an actuary calculates the massive annual contributions you need to make today. For a surgeon in their peak earning years, this can easily be an additional $100,000 to $300,000+ per year in pre-tax contributions.

This is, by far, the largest legal tax deduction available to most high-income professionals. The contribution is a business expense, directly reducing your taxable income. For a surgeon in a high-tax state, a $200,000 contribution could translate into $90,000 or more in combined federal and state tax savings in a single year.

The key difference from a 401(k) is the funding requirement. While you have some flexibility with a 401(k) profit-sharing component, contributions to a cash balance plan are mandatory once the plan is established. You can’t just decide to skip a year because of a market downturn or a dip in practice revenue. This makes it a tool for practices with stable, predictable, and very high cash flow—a perfect fit for a mature refractive surgery practice.

The trap is viewing it as a simple savings account. It’s a formal pension plan governed by ERISA. It requires an actuary, a third-party administrator (TPA), and careful planning. The plan documents are complex, and the investment strategy must be aligned with the actuarial assumptions. It’s a commitment, but for the right physician, it’s an unparalleled tool for accelerating retirement savings and slashing your current tax bill.

The Bad News First: Why the §199A Deduction Fails Most Surgeons

When the Tax Cuts and Jobs Act of 2017 introduced the Section 199A Qualified Business Income (QBI) deduction, it was heralded as a major tax break for small business owners. It allows owners of pass-through entities (like S-Corps and LLCs) to deduct up to 20% of their business income. However, for physicians, there’s a huge catch.

The law specifically defines a “Specified Service Trade or Business” (SSTB), which includes the field of medicine. If your business is an SSTB, your ability to take the QBI deduction is phased out once your taxable income exceeds certain thresholds. For 2026, those thresholds are projected to be around $394,000 for single filers and $787,000 for those married filing jointly. Once your income surpasses the top of the phase-out range, your QBI deduction from your medical practice income is zero.

Let’s be blunt: a successful refractive surgeon, especially a partner in a practice with ASC ownership, will blow past these income thresholds. Most of us figured this out the hard way in the first year or two after the law passed. We spent time and money with accountants trying to see if we could qualify, only to realize our income was simply too high.

The critical takeaway is to stop wasting energy trying to claim the QBI deduction on your primary surgical income. It’s a dead end. The planning trap is paying for complex and often questionable strategies designed to “de-specify” your practice. The IRS is wise to these, and they rarely hold up under scrutiny. Instead of fighting a losing battle, your time and resources are far better spent focusing on the strategies that *do* work at your income level: ASC ownership, real estate, and cash balance plans.

Generating ‘Good’ QBI Outside Your Medical Practice

While your income as a physician is considered “bad” SSTB income for §199A purposes, this doesn’t mean the QBI deduction is completely off the table for you. The key is to generate QBI from non-SSTB activities. This is where the entity structuring we discussed earlier becomes even more powerful.

Remember the real estate LLC that owns your medical building? Rental real estate is generally *not* an SSTB. This means the net rental income generated by that LLC is potentially eligible for the 20% QBI deduction, with no income limitation. So, while your surgical income gets no deduction, your rental income does. This creates a powerful incentive to structure the lease to be profitable (while still being a fair market rate).

Another common strategy is to create a separate equipment leasing company. Your practice might require several million dollars in lasers, diagnostic equipment, and other fixed assets. Instead of the practice owning this equipment directly, you could form a separate S-Corp or LLC that owns the equipment and leases it to the medical practice.

• The practice pays a deductible lease expense.
• The equipment leasing company receives income.

This leasing income is generally not considered SSTB income and is therefore eligible for the QBI deduction. This effectively converts a portion of your practice’s profit into QBI-eligible income. This must be done carefully, with proper documentation, formal lease agreements, and fair market lease rates. You can’t just invent a number; it needs to be defensible. But when structured correctly, it’s a way to claw back some of the §199A benefit that is otherwise lost to high-earning physicians.

The planning trap is co-mingling. These entities must be truly separate—separate books, separate bank accounts, and formal, arm’s-length agreements between them. If the IRS determines your leasing or real estate company has no economic substance and exists solely to service the medical practice, they can disregard the structure.

The economics of a refractive practice go far beyond the per-procedure fee. True financial success lies in building a sophisticated, multi-entity structure that leverages the tax code to your advantage. By layering strategies like ASC ownership, commercial real estate, and advanced retirement plans, you can dramatically reduce your tax burden and accelerate wealth creation, turning high income into lasting equity.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 21, 2026